1. Home
  2. GDRX vs CBLL Comparison

GDRX vs CBLL Comparison

Compare GDRX & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$2.04

Market Cap

868.9M

Sector

Technology

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$18.56

Market Cap

750.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDRX
CBLL
Founded
2011
2014
Country
United States
United States
Employees
N/A
280
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
868.9M
750.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GDRX
CBLL
Price
$2.04
$18.56
Analyst Decision
Buy
Strong Buy
Analyst Count
10
6
Target Price
$3.86
$24.67
AVG Volume (30 Days)
1.8M
258.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
N/A
EPS
0.09
N/A
Revenue
$796,853,000.00
N/A
Revenue This Year
N/A
$29.57
Revenue Next Year
$5.38
$28.44
P/E Ratio
$22.78
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.77
$10.01
52 Week High
$5.61
$24.33

Technical Indicators

Market Signals
Indicator
GDRX
CBLL
Relative Strength Index (RSI) 45.21 47.68
Support Level $1.77 $16.82
Resistance Level $2.47 $19.97
Average True Range (ATR) 0.09 0.75
MACD -0.00 0.04
Stochastic Oscillator 37.50 40.11

Price Performance

Historical Comparison
GDRX
CBLL

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About CBLL CeriBell Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: